VU0155041
Pharmaceutical compound
From Wikipedia, the free encyclopedia
VU0155041 is an experimental drug that is a positive allosteric modulator for the glutamate receptor mGluR4. In animal studies it has anti-Parkinsonian action, reduces neuropathic pain such as allodynia, and counteracts the effects of opioid addiction.[1][2][3][4][5][6][7][8][9]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H15Cl2NO3 |
| Molar mass | 316.18 g·mol−1 |
| 3D model (JSmol) | |
| |
| |